Since the beginning of this year, Hong Kong Stock Exchange has raised the highest amount of funds from IPOs worldwide.

Since the beginning of this year, there have been 87 new IPO listings in the Hong Kong stock market, with a total IPO fundraising exceeding HK$240 billion, ranking first among global exchanges. Leading A-share companies such as CATL, Hansoh Pharmaceutical, and CRRC have successively landed on the Hong Kong Stock Exchange, becoming the main force in the A+H listing craze. As of November 11th, a total of 16 A-share listed companies have successfully landed on the Hong Kong stock market this year, with over 80 A-share listed companies queuing up for listing on the Hong Kong Stock Exchange. Additionally, many A-share listed companies, including Intco Medical, have announced their intention to list on the Hong Kong Stock Exchange but have not yet submitted their applications. Furthermore, over 300 companies have submitted applications to the Hong Kong Stock Exchange this year, reaching a new annual high. Institutional experts believe that the scale of Hong Kong stock IPOs has significantly rebounded this year, with leading enterprises from various industries in the A-share market queuing up for listing, potentially further optimizing the structure of the Hong Kong stock market. This is expected to better reflect the structural direction of the Chinese economy, and the listing of high-quality companies in Hong Kong will further enhance the asset quality and liquidity level of the Hong Kong stock market.